Cargando…

Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients

BACKGROUND: Recently, we produced a tumour antigen-presenting cells (TAPCells) vaccine using a melanoma cell lysate, called TRIMEL, as an antigen source and an activation factor. Tumour antigen-presenting cells induced immunological responses and increased melanoma patient survival. Herein, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reyes, D, Salazar, L, Espinoza, E, Pereda, C, Castellón, E, Valdevenito, R, Huidobro, C, Inés Becker, M, Lladser, A, López, M N, Salazar-Onfray, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777003/ https://www.ncbi.nlm.nih.gov/pubmed/23989944 http://dx.doi.org/10.1038/bjc.2013.494

Ejemplares similares

Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy
por: González, Fermín E., et al.
Publicado: (2018)

IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming
por: Medel, Bernardita, et al.
Publicado: (2019)

Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses In Vitro
por: Flores, Iván, et al.
Publicado: (2019)

A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth
por: Gleisner, María Alejandra, et al.
Publicado: (2020)

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
por: Rojas-Sepúlveda, Daniel, et al.
Publicado: (2018)

Role of Dendritic Cells in the Induction of Lymphocyte Tolerance
por: Osorio, Fabiola, et al.
Publicado: (2015)

Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

Correction: Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles
por: Win, S J, et al.
Publicado: (2012)

Hypoxic Melanoma Cells Deliver microRNAs to Dendritic Cells and Cytotoxic T Lymphocytes through Connexin-43 Channels
por: Tittarelli, Andrés, et al.
Publicado: (2020)

Caveolin-1 Expression Increases upon Maturation in Dendritic Cells and Promotes Their Migration to Lymph Nodes Thereby Favoring the Induction of CD8(+) T Cell Responses
por: Oyarce, Cesar, et al.
Publicado: (2017)

Haptoglobin Induces a Specific Proteomic Profile and a Mature-Associated Phenotype on Primary Human Monocyte-Derived Dendritic Cells
por: Torres, Alfredo, et al.
Publicado: (2022)

Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
por: Pasqualetti, Francesco, et al.
Publicado: (2023)

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
por: Santin, A D, et al.
Publicado: (2002)

Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy
por: García-Salum, Tamara, et al.
Publicado: (2018)

Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma
por: Parney, Ian F, et al.
Publicado: (2020)

Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
por: Fiammenghi, Laura, et al.
Publicado: (2010)

Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
por: Lopez, Ernesto, et al.
Publicado: (2023)

Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines
por: Tomić, Sergej, et al.
Publicado: (2021)

Comparison of four methods of colon cancer cell lysates preparation for ex vivo maturation of dendritic cells
por: Roufarshbaf, Mohammad, et al.
Publicado: (2021)

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
por: Yamanaka, R, et al.
Publicado: (2003)

Immunogenicity of Exosomes from Dendritic Cells Stimulated with Toxoplasma gondii Lysates in Ocularly Immunized Mice
por: Jung, Bong-Kwang, et al.
Publicado: (2020)

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
por: Boudousquié, Caroline, et al.
Publicado: (2020)

Quality of tumor lysates used for pulsing dendritic cells is influenced by the method used to harvest adherent tumor cells
por: Herzog, Gloria Isabelle, et al.
Publicado: (2011)

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro
por: Ghorbaninezhad, Farid, et al.
Publicado: (2022)

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
por: Kandalaft, Lana E, et al.
Publicado: (2013)

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2018)

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
por: Ribas, Antoni, et al.
Publicado: (2010)

Comparative Analysis of Cytotoxic T Lymphocyte Response Induced by Dendritic Cells Loaded with Hepatocellular Carcinoma -Derived RNA or Cell Lysate
por: Pan, Ke, et al.
Publicado: (2010)

Dendritic Cells Loaded with Pancreatic Cancer Stem Cells (CSCs) Lysates Induce Antitumor Immune Killing Effect In Vitro
por: Yin, Tao, et al.
Publicado: (2014)

Dendritic cells loaded with CD44(+) CT-26 colon cell lysate evoke potent antitumor immune responses
por: Fu, Changhao, et al.
Publicado: (2019)

The Effects of Castration and Stilboestrol on Prostatic Tumours in Mice
por: Horning, E. S.
Publicado: (1949)

Vaccination-induced skin-resident memory CD8(+) T cells mediate strong protection against cutaneous melanoma
por: Gálvez-Cancino, Felipe, et al.
Publicado: (2018)

Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
por: Chiang, Cheryl L-L, et al.
Publicado: (2011)

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
por: Parney, Ian F, et al.
Publicado: (2022)

CD73 Ectonucleotidase Restrains CD8+ T Cell Metabolic Fitness and Anti-tumoral Activity
por: Briceño, Pedro, et al.
Publicado: (2021)

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2014)

Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulated Autologous T lymphocyte Cytotoxicity
por: Kukia, Nasim Rahmani, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v1loh6kl8inqhe1jc0ic9sim2u